Calendula Officinalis, Chamomilla, Nux Vomica, Pulsatilla (pratensis), Belladonna, Colocynthis, Magnesia Phosphorica
Generic Name: calendula officinalis, chamomilla, nux vomica, pulsatilla (pratensis), belladonna, colocynthis, magnesia phosphorica
Dosage form: LIQUID. Active ingredients: ATROPA BELLADONNA (15 [hp_C]/mL); CALENDULA OFFICINALIS FLOWERING TOP (3 [hp_X]/mL); CITRULLUS COLOCYNTHIS FRUIT PULP (15 [hp_C]/mL); MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE (15 [hp_C]/mL); MATRICARIA CHAMOMILLA WHOLE (3 [hp_X]/mL); PULSATILLA PRATENSIS WHOLE (6 [hp_C]/mL); STRYCHNOS NUX-VOMICA SEED (6 [hp_C]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: ATROPA BELLADONNA (15 [hp_C]/mL); CALENDULA OFFICINALIS FLOWERING TOP (3 [hp_X]/mL); CITRULLUS COLOCYNTHIS FRUIT PULP (15 [hp_C]/mL); MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE (15 [hp_C]/mL); MATRICARIA CHAMOMILLA WHOLE (3 [hp_X]/mL); PULSATILLA PRATENSIS WHOLE (6 [hp_C]/mL); STRYCHNOS NUX-VOMICA SEED (6 [hp_C]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Belatacept
belatacept
Selective T Cell Costimulation Blocker [EPC]
11 DESCRIPTION NULOJIX ® (belatacept), a selective T cell costimulation blocker, is a soluble fusion protein consisting of the modified extracellular domain of CTLA-4 fused to a portion (hinge-CH2-CH3 domains) of the Fc domain of a human immunoglobulin G1 antibody. Belatacept is produced by recombinant DNA technology in a mammalian cell expression system. Two amino acid substitutions (L104 to E; A29 to Y) were made in the ligand binding region of CTLA-4.
Ubidecarenone
ubidecarenone
Dosage form: POWDER. Active ingredients: UBIDECARENONE (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Solifenacin Succinate Api
solifenacin succinate api
Dosage form: POWDER. Active ingredients: SOLIFENACIN SUCCINATE (1 kg/kg). Category: BULK INGREDIENT.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.